![Eric Thorin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric Thorin
Fundador en Gene Signal International SA .
Perfil
Eric Thorin is the founder of Gene Signal International SA, a company founded in 2000.
He holds the title of Director & Chief Development Officer at Gene Signal International SA. Dr. Thorin also held the position of Head-Cardiovascular Pharmacology at Actelion Pharmaceuticals, Inc. (France).
Cargos activos de Eric Thorin
Empresas | Cargo | Inicio |
---|---|---|
Gene Signal International SA
![]() Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Fundador | 01/01/2000 |
Antiguos cargos conocidos de Eric Thorin.
Empresas | Cargo | Fin |
---|---|---|
Actelion Pharmaceuticals, Inc. (France)
![]() Actelion Pharmaceuticals, Inc. (France) Industrial SpecialtiesProcess Industries Actelion Pharmaceuticals, Inc. (France) is a private company based in Le Pin, France. and has subsidiaries in France. Actelion Pharmaceuticals, Inc. manufactures insulation materials. The French company was founded by Annick Schwebig. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Gene Signal International SA
![]() Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Health Technology |
Actelion Pharmaceuticals, Inc. (France)
![]() Actelion Pharmaceuticals, Inc. (France) Industrial SpecialtiesProcess Industries Actelion Pharmaceuticals, Inc. (France) is a private company based in Le Pin, France. and has subsidiaries in France. Actelion Pharmaceuticals, Inc. manufactures insulation materials. The French company was founded by Annick Schwebig. | Process Industries |
- Bolsa de valores
- Insiders
- Eric Thorin